Literature DB >> 21255731

Structure of a preternary complex involving a prokaryotic NHEJ DNA polymerase.

Nigel C Brissett1, Maria J Martin, Robert S Pitcher, Julie Bianchi, Raquel Juarez, Andrew J Green, Gavin C Fox, Luis Blanco, Aidan J Doherty.   

Abstract

In many prokaryotes, a specific DNA primase/polymerase (PolDom) is required for nonhomologous end joining (NHEJ) repair of DNA double-strand breaks (DSBs). Here, we report the crystal structure of a catalytically active conformation of Mycobacterium tuberculosis PolDom, consisting of a polymerase bound to a DNA end with a 3' overhang, two metal ions, and an incoming nucleotide but, significantly, lacking a primer strand. This structure represents a polymerase:DNA complex in a preternary intermediate state. This polymerase complex occurs in solution, stabilizing the enzyme on DNA ends and promoting nucleotide extension of short incoming termini. We also demonstrate that the invariant Arg(220), contained in a conserved loop (loop 2), plays an essential role in catalysis by regulating binding of a second metal ion in the active site. We propose that this NHEJ intermediate facilitates extension reactions involving critically short or noncomplementary DNA ends, thus promoting break repair and minimizing sequence loss during DSB repair. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21255731     DOI: 10.1016/j.molcel.2010.12.026

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  27 in total

1.  Structural evidence for an in trans base selection mechanism involving Loop1 in polymerase μ at an NHEJ double-strand break junction.

Authors:  Jérôme Loc'h; Christina A Gerodimos; Sandrine Rosario; Mustafa Tekpinar; Michael R Lieber; Marc Delarue
Journal:  J Biol Chem       Date:  2019-05-28       Impact factor: 5.157

2.  Withdrawn

Authors: 
Journal:  Infect Disord Drug Targets       Date:  2012-11-16

3.  Human PrimPol mutation associated with high myopia has a DNA replication defect.

Authors:  Benjamin A Keen; Laura J Bailey; Stanislaw K Jozwiakowski; Aidan J Doherty
Journal:  Nucleic Acids Res       Date:  2014-09-27       Impact factor: 16.971

4.  Structural basis for a novel mechanism of DNA bridging and alignment in eukaryotic DSB DNA repair.

Authors:  Jérôme Gouge; Sandrine Rosario; Félix Romain; Frédéric Poitevin; Pierre Béguin; Marc Delarue
Journal:  EMBO J       Date:  2015-03-11       Impact factor: 11.598

5.  Ribonucleolytic resection is required for repair of strand displaced nonhomologous end-joining intermediates.

Authors:  Edward J Bartlett; Nigel C Brissett; Aidan J Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-13       Impact factor: 11.205

6.  Insights into eukaryotic primer synthesis from structures of the p48 subunit of human DNA primase.

Authors:  Sivaraja Vaithiyalingam; Diana R Arnett; Amit Aggarwal; Brandt F Eichman; Ellen Fanning; Walter J Chazin
Journal:  J Mol Biol       Date:  2013-11-13       Impact factor: 5.469

7.  Characterization of Mycobacterium smegmatis PolD2 and PolD1 as RNA/DNA polymerases homologous to the POL domain of bacterial DNA ligase D.

Authors:  Hui Zhu; Hitesh Bhattarai; Han-Guang Yan; Stewart Shuman; Michael S Glickman
Journal:  Biochemistry       Date:  2012-12-11       Impact factor: 3.162

8.  Solution structure and DNA-binding properties of the phosphoesterase domain of DNA ligase D.

Authors:  Aswin Natarajan; Kaushik Dutta; Deniz B Temel; Pravin A Nair; Stewart Shuman; Ranajeet Ghose
Journal:  Nucleic Acids Res       Date:  2011-11-13       Impact factor: 16.971

Review 9.  Primase-polymerases are a functionally diverse superfamily of replication and repair enzymes.

Authors:  Thomas A Guilliam; Benjamin A Keen; Nigel C Brissett; Aidan J Doherty
Journal:  Nucleic Acids Res       Date:  2015-06-24       Impact factor: 16.971

10.  The minimal Bacillus subtilis nonhomologous end joining repair machinery.

Authors:  Miguel de Vega
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.